Global Medical Affairs Planning & Effectiveness, Content Platform Lead -Job 2033
Ascendis Pharma
Summary
The Global Medical Affairs Planning & Effectiveness, Medical Content Platform Lead is responsible for leading the global operating model, governance framework, and technology strategy for Medical Affairs content management and review processes within Veeva MedComms. This role serves as the business owner for Medical content platforms and capabilities, including Veeva MedComms and related systems, ensuring a scalable, compliant, and efficient framework for content creation, review, approval, distribution, and utilization across global and local markets.
Job description
Key Responsibilities
Global Content Governance and Operating Model
- Own and evolve the global Medical content governance framework, including policies, standards, taxonomy, metadata strategy, content architecture, and lifecycle management.
- Establish and maintain an integrated operating model across Medical Affairs, Regulatory Affairs, Market Access, Commercial, and IT to ensure content systems function as a coordinated enterprise capability.
- Define governance structures, decision rights, prioritization frameworks, and cross-functional steering committees to support effective content operations.
- Lead resolution of competing stakeholder priorities and drive decisions that balance compliance, usability, scalability, and business objectives.
- Develop global standards for content repositories while minimizing duplication and ensuring alignment with enterprise architecture principles.
- Establish and maintain content management best practices and ensure consistent adoption across regions and functions.
Platform Ownership and Technology Strategy
- Serve as the senior business owner and primary Medical Affairs representative for MedComms and related content management platforms.
- Partner closely with IT to define platform roadmaps, enhancement priorities, investment strategies, and long-term capability development.
- Translate business requirements into scalable technical solutions and ensure alignment with Medical Affairs strategic objectives.
- Lead governance and prioritization of system enhancements, backlog management, taxonomy changes, workflow optimizations, and new capability implementation.
- Oversee platform adoption, training, user support models, and change management initiatives.
- Collaborate with vendors and internal technical teams to optimize system performance and user experience.
Content Review and Approval Excellence
- Provide strategic oversight for medical and non-promotional content review processes globally.
- Ensure compliant, efficient, and consistent review workflows across cross-functional stakeholders.
- Establish standards and best practices for content submission, review, approval, documentation, and audit readiness.
- Oversee review governance forums, prioritization processes, escalation pathways, and decision documentation.
- Guide support of product launches, new indications, data disclosures, and label updates through effective content review planning.
- Drive continuous process improvement initiatives to reduce cycle times and enhance review quality.
Cross-Functional Leadership
- Act as the primary liaison among Medical Affairs, Regulatory Affairs, Market Access, Commercial, Legal, Compliance, and Information Technology.
- Build strong relationships with senior leaders to align priorities and advance enterprise initiatives.
- Chair governance committees and facilitate strategic discussions related to content operations and platform capabilities.
- Influence stakeholders across organizational boundaries without direct authority.
- Foster collaboration and accountability across global functions and markets.
Analytics, Metrics, and Operational Performance
- Develop and maintain global performance measurement frameworks for content operations and governance effectiveness.
- Define key performance indicators related to adoption, utilization, review efficiency, compliance, content accessibility, and operational effectiveness.
- Create executive dashboards and reporting capabilities that provide visibility into system performance and business outcomes.
- Monitor trends and identify opportunities for optimization and innovation.
- Establish market-level targets and benchmarks to support continuous improvement.
Change Management and Capability Building
- Lead global change management strategies supporting new processes, governance models, and technology initiatives.
- Develop communication plans, training programs, knowledge resources, and adoption campaigns.
- Promote awareness and accessibility of available content and platform capabilities.
- Build organizational capability through education, coaching, and stakeholder engagement.
- Support development of future-state operating models that enhance effectiveness and scalability across the organization.
Requirements
- Bachelor's degree required
- Advanced degree in Life Sciences, Business Administration, Healthcare Management, Information Management, or related field preferred
- Minimum 7 years of progressively responsible experience within the pharmaceutical, biotechnology, or healthcare industry
- Significant experience in Medical Affairs operations, content governance, non-promotional review, or regulated content management environments
- Demonstrated expertise with Veeva MedComms, Medical content management systems, electronic document management systems, and associated workflows
- Experience leading global cross-functional initiatives and governance programs
- Proven track record driving business process transformation and technology-enabled operational improvements
- Experience partnering effectively with Information Technology organizations and managing enterprise platform strategies
- Strategic leadership and enterprise thinking
- Deep understanding of Medical Affairs operations and scientific content workflows
- Expertise in content governance, taxonomy, metadata, and repository architecture
- Strong knowledge of regulated content review and approval processes
- Ability to translate complex business needs into scalable operational and technical solutions
- Exceptional influencing and stakeholder management skills
- Experience establishing governance structures, decision rights, and prioritization frameworks
- Strong business process ownership within highly regulated environments
- Excellent communication, facilitation, and executive presentation skills
- Strong analytical capability with experience building metrics and performance dashboards
- Sound decision-making and judgment in complex organizational situations
- Project and change management expertise
- Ability to balance consensus-building with decisive leadership
Benefits
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
- Paid Time Off
- 401(k) With Company Match
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- AD&D Insurance
- Short-Term Disability Benefits
- Long-Term Disability Benefits
- Pet Insurance
- Legal Insurance
- Employee Assistance Program
- Employee Discounts
- Professional Development
- Health Savings Account
- Flexible Spending Accounts
- Accident Insurance
- Critical Illness Insurance
- Hospital Indemnity Insurance
- Mental Health Resources
- Paid Parental Leave
Company overview
Ascendis Pharma is a global biopharmaceutical company founded in 2007 and headquartered in Hellerup, Denmark, with additional facilities across Europe and the United States. The company is publicly traded on Nasdaq under the symbol ASND. Ascendis Pharma specializes in applying its innovative TransCon technology platform to develop novel therapies that address unmet medical needs in endocrinology rare diseases and oncology. The company's core values of Patients, Science, and Passion guide its mission to create potentially best-in-class therapies. Ascendis has two marketed products: SKYTROFA (lonapegsomatropin-tcgd) for pediatric growth hormone deficiency and YORVIPATH (palopegteriparatide) for adult hypoparathyroidism. The company's pipeline includes TransCon CNP for achondroplasia and oncology candidates like TransCon TLR7/8 Agonist and TransCon IL-2 β/γ. With approximately 1,017 employees globally as of December 2024, Ascendis operates through a combination of direct commercialization in key markets and strategic partnerships in regions like Greater China and Japan through VISEN Pharmaceuticals and Teijin Limited, respectively.